Summary of Study ST000860
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000575. The data can be accessed directly via it's Project DOI: 10.21228/M8BM2Z This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000860 |
Study Title | Targeted Sphingomyelin Concentrations in Kallikrein 6 Mice after SCI |
Study Summary | Targeted Sphingomyelin in Kallikrein 6 Mice after SCI. The samples submitted are purified myelin preparations from the postnatal day 21, 60, or 90 mouse spinal cord (SC). There are 12 samples total in Project 3, n=3 for K6+/+ or K6-/- at either P21 or P90. |
Institute | Mayo Clinic |
Last Name | Scarisbrick |
First Name | Isobel |
Address | 200 First Street SW, Rochester, MN 55905 |
scarisbrick.isobel@mayo.edu | |
Phone | 507-284-0124 |
Submit Date | 2017-08-10 |
Analysis Type Detail | LC-MS |
Release Date | 2021-02-17 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR000901 |
Treatment Summary: | A 3g Clip produces moderate SCI including demyelination and clinical impairment and we recently published a detailed methodology. At 1 week after injury, the 3g injured mice are expected to have an average Basso Mouse Scale score (BMS)=5 on a 9 point scale such that they have frequent plantar stepping with no or some coordination. This level of impairment was chosen to provide a sufficient window to observe recovery. |